NASDAQ:APYX

Apyx Medical - APYX Stock Forecast, Price & News

$1.83

+0.01 (+0.55%)

(As of 12/7/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.75
▼
$1.85
50-Day Range: $1.40
▼
$5.02
52-Week Range: $1.31
▼
$14.50

Volume: 106,022 shs
Average Volume: 351,627 shs
Market Capitalization: $63.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.67

Apyx Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 318.9% Upside
$7.67 Price Target
Short Interest: Bearish
4.01% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.05
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.64) to ($0.55) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

491st out of 1,027 stocks

Surgical & Medical Instruments Industry

54th out of 101 stocks

3.4

Analyst's Opinion

Consensus Rating
Apyx Medical has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $7.67, Apyx Medical has a forecasted upside of 318.9% from its current price of $1.83.
Amount of Analyst Coverage
Apyx Medical has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.01% of the float of Apyx Medical has been sold short.
Short Interest Ratio / Days to Cover
Apyx Medical has a short interest ratio ("days to cover") of 4.1.
Change versus previous month
Short interest in Apyx Medical has recently increased by 42.55%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Apyx Medical does not currently pay a dividend.
Dividend Growth
Apyx Medical does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Apyx Medical has received a 59.87% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.
Environmental Sustainability
The Environmental Impact score for Apyx Medical is -1.05.

1.1

News and Social Media Coverage

Search Interest
11 people have searched for APYX on MarketBeat in the last 30 days. This is an increase of 450% compared to the previous 30 days.
MarketBeat Follows
3 people have added Apyx Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Apyx Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
11.60% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
60.85% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Apyx Medical are expected to grow in the coming year, from ($0.64) to ($0.55) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Apyx Medical is -3.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Apyx Medical is -3.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Apyx Medical has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Apyx Medical (NASDAQ:APYX) Stock

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Stock News Headlines

November 27, 2022 | americanbankingnews.com

Critical Comparison: Motus GI (NASDAQ:MOTS) and Apyx Medical (NASDAQ:APYX)

November 23, 2022 | 247wallst.com

Archon Capital Ups Stake in Apyx Medical (APYX) After Q3 Results

December 7, 2022 | Investing Trends (Ad)

The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?

Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts.

November 22, 2022 | finance.yahoo.com

Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference

November 14, 2022 | seekingalpha.com

Apyx Medical Corporation (APYX) Q3 2022 Earnings Call Transcript

November 12, 2022 | finance.yahoo.com

Apyx Medical Third Quarter 2022 Earnings: Misses Expectations

November 10, 2022 | seekingalpha.com

Apyx Medical reports Q3 earnings miss; narrows FY22 revenue guidance below estimates

November 10, 2022 | marketwatch.com

Apyx Medical Shares Drop 64% On Lower 3Q Sales, Cut FY View

December 7, 2022 | Investing Trends (Ad)

The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?

November 10, 2022 | msn.com

What Does Apyx Medical's Debt Look Like?

November 10, 2022 | finance.yahoo.com

Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

November 10, 2022 | finance.yahoo.com

Apyx Medical (APYX) Reports Q3 Loss, Misses Revenue Estimates

October 20, 2022 | marketwatch.com

Medical Grounding Pads Market 2022 : Opportunities in Future, Business Growth Analysis by Top Countries Data and Industry Players by 2028

October 20, 2022 | benzinga.com

Global Medical Sensors Market to Surpass US$ 44,507.6 Million by 2030, Says Coherent Market Insights (CMI)

October 18, 2022 | marketwatch.com

Cold Plasma Equipment Market 2022 Advance Technology, Latest Trend and Future Expansion by 2028

September 29, 2022 | finance.yahoo.com

Apyx Medical (NASDAQ:APYX) Is In A Good Position To Deliver On Growth Plans

September 26, 2022 | finance.yahoo.com

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022

September 13, 2022 | markets.businessinsider.com

'BOTCHED' TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION® HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURES

September 7, 2022 | msn.com

6APYX : Looking Into Apyx Medical's Return On Capital Employed

September 6, 2022 | finance.yahoo.com

Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference

September 2, 2022 | nasdaq.com

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

September 2, 2022 | finance.yahoo.com

One Apyx Medical Corporation (NASDAQ:APYX) insider upped their stake by 42% in the previous year

August 14, 2022 | seekingalpha.com

Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call Transcript

August 13, 2022 | benzinga.com

4APYX : Apyx Medical: Q2 Earnings Insights

August 11, 2022 | finance.yahoo.com

Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

August 9, 2022 | nz.finance.yahoo.com

The Global Cold Plasma Market grew USD 4,932.72 million by 2027, at a CAGR of 17.32%.

August 5, 2022 | benzinga.com

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Company Calendar

Last Earnings: 11/10/2022
Today: 12/07/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 3/16/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:APYX
CUSIP: N/A
CIK: 719135
Web: www.apyxmedical.com
Phone: (727) 384-2323
Fax: 800-323-1640
Employees: 272
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $7.67
High Stock Price Forecast: $10.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +318.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.56)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-15,170,000.00
Net Margins: -39.28%
Pretax Margin: -38.74%
Return on Equity: -39.82%
Return on Assets: -31.06%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.14
Quick Ratio: 3.06

Sales & Book Value

Annual Sales: $48.52 million
Price / Sales: 1.30
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.57 per share
Price / Book: 1.17

Miscellaneous

Outstanding Shares: 34,598,000
Free Float: 30,585,000
Market Cap: $63.31 million
Optionable: Optionable
Beta: 1.36

Key Executives

Mr. Charles D. Goodwin II (Age 56)
Pres, CEO & Director
Comp: $892.97k

Ms. Tara H. Semb (Age 52)
CFO, Treasurer & Sec.
Comp: $531.67k

Mr. Moshe Citronowicz (Age 69)
Sr. VP
Comp: $432.49k

Mr. Todd Hornsby (Age 46)
Exec. VP
Comp: $590.66k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

APYX Stock - Frequently Asked Questions

Should I buy or sell Apyx Medical stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" APYX shares.
View APYX analyst ratings or view top-rated stocks.
What is Apyx Medical's stock price forecast for 2023?: 4 equities research analysts have issued twelve-month price targets for Apyx Medical's shares. Their APYX share price forecasts range from $3.00 to $10.00. On average, they predict the company's share price to reach $7.67 in the next year. This suggests a possible upside of 318.9% from the stock's current price.
View analysts price targets for APYX or view top-rated stocks among Wall Street analysts.
How have APYX shares performed in 2022?: Apyx Medical's stock was trading at $12.82 at the beginning of 2022. Since then, APYX stock has decreased by 85.7% and is now trading at $1.83.
View the best growth stocks for 2022 here.
When is Apyx Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023.
View our APYX earnings forecast.
How were Apyx Medical's earnings last quarter?: Apyx Medical Co. (NASDAQ:APYX) released its earnings results on Thursday, November, 10th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.05. The firm earned $9.11 million during the quarter, compared to analysts' expectations of $12 million. Apyx Medical had a negative net margin of 39.28% and a negative trailing twelve-month return on equity of 39.82%.
What guidance has Apyx Medical issued on next quarter's earnings?: Apyx Medical issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $44.80 million-$47.90 million, compared to the consensus revenue estimate of $53.47 million.

What other stocks do shareholders of Apyx Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).
What is Apyx Medical's stock symbol?: Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."
Who are Apyx Medical's major shareholders?: Apyx Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pura Vida Investments LLC (4.36%), Vanguard Group Inc. (4.09%), Kent Lake Capital LLC (3.03%), Invenire Partners LP (2.74%), UBS Group AG (2.57%) and Royce & Associates LP (2.56%).
View institutional ownership trends.
How do I buy shares of Apyx Medical?: Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Apyx Medical's stock price today?: One share of APYX stock can currently be purchased for approximately $1.83.
How much money does Apyx Medical make?: Apyx Medical (NASDAQ:APYX) has a market capitalization of $63.31 million and generates $48.52 million in revenue each year. The company earns $-15,170,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.
How many employees does Apyx Medical have?: The company employs 272 workers across the globe.
How can I contact Apyx Medical?: Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The official website for the company is www.apyxmedical.com. The company can be reached via phone at (727) 384-2323, via email at investor.relations@apyxmedical.com, or via fax at 800-323-1640.

This page (NASDAQ:APYX) was last updated on 12/7/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial